Drugs for Neglected Diseases Initiative Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by Drugs for Neglected Diseases Initiative and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 253 Drugs for Neglected Diseases Initiative employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Drugs for Neglected Diseases Initiative has purchased the following applications: SAS Analytics Pro for Analytics and BI in 2020, Microsoft 365 for Collaboration in 2015, DocuSign eSignature for Digital Signing in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Drugs for Neglected Diseases Initiative is running and its propensity to invest more and deepen its relationship with SAS Institute , Microsoft , DocuSign or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Drugs for Neglected Diseases Initiative revenues, which have grown to $71.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Drugs for Neglected Diseases Initiative intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Analytics and BI
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| SAS Institute | Legacy | SAS Analytics Pro | Analytics and BI | Analytics and BI | n/a | 2020 | 2020 |
In 2020, Drugs for Neglected Diseases Initiative deployed SAS Analytics Pro to standardise, validate, and clean clinical trial data and to automate regulatory and donor financial reporting, using the solution within the Analytics and BI category. The implementation targeted clinical research and finance functions and was executed to support reporting and submissions across multiple countries.
SAS Analytics Pro was configured to enforce data standardization and validation rules and to orchestrate data cleansing and transformation pipelines for trial datasets and financial records. Reporting automation capability produced regulatory submission packages and donor reporting outputs with scheduled processing and repeatable analytics workflows. The deployment leveraged the product's native data management and analytics modules to centralise data quality controls.
Operational coverage included clinical operations teams and finance groups across DNDi country programs, aligning clinical trial metadata with financial reporting requirements. Governance was formalised through standardized validation rules and automated reporting schedules which reduced manual reconciliation between research and finance datasets. Process changes emphasized instrumentation of data quality checkpoints and handoffs into regulatory submission workflows.
The rollout improved data integrity and transparency for regulatory submissions and donor reporting, and the organization benefited from SAS's Data for Good support in strengthening reporting automation. SAS Analytics Pro, as used by Drugs for Neglected Diseases Initiative in 2020, connected Analytics and BI capabilities to core clinical research and finance business functions.
|
Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2015 | 2015 |
|
Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DocuSign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2021 | 2021 |
|
 |
|
|
Web Content Management | Content Management |
|
2010 | 2010 |
|
CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Customer Experience | CRM |
|
2018 | 2018 |
|
|
|
|
|
Marketing Analytics | CRM |
|
2018 | 2018 |
|
|
|
|
|
Marketing Automation | CRM |
|
2019 | 2019 |
|
|
|
|
|
Marketing Automation | CRM |
|
2020 | 2020 |
|
|
|
|
|
Tag Management | CRM |
|
2018 | 2018 |
|
IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2013 | 2013 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2014 | 2014 |
|
|
|
|
|
Cloud Storage | IaaS |
|
2011 | 2011 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2023 | 2023 |
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||